stronger neominophagen c has been researched along with lamivudine in 1 studies
| Studies (stronger neominophagen c) | Trials (stronger neominophagen c) | Recent Studies (post-2010) (stronger neominophagen c) | Studies (lamivudine) | Trials (lamivudine) | Recent Studies (post-2010) (lamivudine) |
|---|---|---|---|---|---|
| 18 | 2 | 8 | 7,025 | 1,425 | 2,177 |
| Protein | Taxonomy | stronger neominophagen c (IC50) | lamivudine (IC50) |
|---|---|---|---|
| Capsid protein | Hepatitis B virus | 0.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, M; Genka, I; Kikuchi, Y; Oka, S; Tachikawa, N; Teruya, K; Yamaguchi, M; Yamamoto, Y; Yasuoka, A; Yasuoka, C | 1 |
1 other study(ies) available for stronger neominophagen c and lamivudine
| Article | Year |
|---|---|
Mitigation of hepato-cellular injury caused by HAART with glycyrrhizin compound in patients co-infected with HIV and HCV.
Topics: Anti-HIV Agents; Chemical and Drug Induced Liver Injury; Cysteine; Drug Combinations; Drug Therapy, Combination; Glycine; Glycyrrhetinic Acid; Hemophilia A; Hepatitis C; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Stavudine; Viral Load; Zalcitabine; Zidovudine | 1999 |